Veeva Systems, has announced Veeva data cloud to help support the industry by bringing greater innovation and choice to the data market. Veeva data cloud will include longitudinal patient and prescriber data offerings that will cover retail and specialty distribution channels, initially tailored for commercial use cases such as launch planning, patient segmentation, commercial analytics, AI, territory design, targeting, and incentive compensation.
Asaf Evenhaim, CEO of Crossix, is leading the development of Veeva data cloud. Veeva data cloud is powered by the Crossix Data Platform, a technology platform built for the development and delivery of large-scale patient data and analytics. The Crossix Data Platform combines technology, privacy-safe processes, and continually expanding health data sets. Veeva data cloud will have the same open and customer-friendly usage agreements that exist with other Veeva data solutions like Veeva OpenData.
“The life sciences industry needs a new, modern approach to patient and prescriber data,” said Peter Gassner, founder and CEO of Veeva. “We aim to bring innovation and choice to the market and an open approach centered on customer success.”
Veeva data cloud’s’s longitudinal patient and prescriber data solution for the U.S. market is expected to be available by December 2020 and will focus primarily on specialty distribution channels. Offerings for additional countries will follow in the coming years, enabled by a combination of Veeva product development, industry partnerships, and acquisitions.